期刊文献+

富马酸卢帕他定的合成

Synthesis of Rupatadine Fumarate
原文传递
导出
摘要 以烟酸乙酯(4)和间氯苯乙腈(5)为原料,经克莱森缩合、酸水解脱羧反应,得2-(3-氯苯基)-1-(吡啶-3-基)-1-乙酮(6)。6与水合肼经黄鸣龙还原反应,得3-(3-氯苯乙基)吡啶(7),7在钨酸钠催化下经过氧化氢氧化后,再经Reissert-Henze吡啶氰基化反应,得3-(3-氯苯乙基)-2-氰基吡啶(8),水解后闭环得8-氯-10,11-二氢-4-氮杂-5H-二苯并[a,d]-5-环庚酮(3),再与1-[(5-甲基吡啶-3-基)甲基]-4-哌啶酮(12)经McMurry偶联反应,并与富马酸成盐,得到富马酸卢帕他定(1),总收率28.0%(以4计),纯度99.7%。该路线避免格氏试剂的使用,且环合反应使用“一锅法”,操作方便,适合工业化生产。 Starting with ethyl nicotinate(4)and 3-chlorobenzyl cyanide(5)as raw materials,through the Claisen condensation,acid hydrolysis and decarboxylation,2-(3-chlorophenyl)-1-(pyridin-3-yl)-1-ethanone(6)was obtained.Compound 3-(3-chlorophenethyl)pyridine(7)was generated by Huang Minglong reduction with hydrazine hydrate.After sodium tungstate catalysis and subsequent oxidation with hydrogen peroxide,followed by the Reissert-Henze pyridine cyanation reaction,3-(3-chlorophenethyl)-2-cyanopyridine(8)was obtained.After hydrolysis and ring closure,8-chloro-10,11-dihydro-4-aza-5H-dibenzo[a,d]cyclohept-5-one(3)was obtained.Then compound 3 reacted with 1-[(5-methylpyridin-3-yl)methyl]-4-piperidone(12)by McMurry coupling reaction and salted with fumaric acid,resulting in rupatadine fumarate(1).The overall yield was 28.0%(based on 4),with a purity of 99.7%.This synthetic route avoids the use of Grignard reagents.Additionally,the cyclization employs a one-pot"method,providing convenient operation and suitability for industrial production.
作者 韩英昂 滕大为 龙中柱 蔡畅 蔡水洪 HAN Ying'ang;TENG Dawei;LONG Zhongzhu;CAI Chang;CAI Shuihong(College of Chemistry Engineering,Qingdao University of Science and Technology,Qingdao 266042;Qidong Dongyue Pharmaceutical Co.,Ltd.,Nantong 226251)
出处 《中国医药工业杂志》 EI CAS CSCD 2024年第1期48-52,共5页 Chinese Journal of Pharmaceuticals
关键词 富马酸卢帕他定 抗组胺药 合成 rupatadine fumarate antihistaminics synthesis
  • 相关文献

参考文献5

二级参考文献20

  • 1王震宇,朱雄,王尔华.卢帕他定中间体5-甲基吡啶-3-羧酸的合成工艺改进[J].药学进展,2005,29(1):31-33. 被引量:3
  • 2张万金,罗艳,张燕梅.卢帕他定的合成[J].中国医药工业杂志,2006,37(7):433-435. 被引量:7
  • 3DuBuske L M.Second-generation antihistamines:The risk of ventricular arrhythmias[J]. Clin Ther,1999,21(2):281-295.
  • 4Piwinski J J,Wong J K,Green M J,et al.Dual antagonist of plateled activation factor and histamine:Identification of structural requirements for dual activity of N-acyl-4-(5,6-dihydro-1H-benzo[5,6]cyclophepta[1,2-b]pyridin-11-ylidene)piperidines[J]. J Med Chem,1991,34:457-461.
  • 5Schumacher D P, Murphy B L,Dark J E, et al. Superacid cyclodehydration of ketones in the production of tricyclic antihistamines[J]. J Org Chem,1989,54:2 242-2 244.
  • 6Frank J, Peter V, Daniels J L, et al. Derivative of 10,11-dihydro-5H-dibenzo[a,d]cycloheptone and related compounds:Ⅲ.Azaketones(1,2)[J]. J Heterocyclic Chem,1971,8:73-81.
  • 7Karimian K, Lee S, Jackson W P, et al. Methods for the manufacture of loratadine, intermediates useful in the manufacture thereof[P].CA:2134128,1996-04-25.
  • 8Tamarang S A.8-Chloro-6,11-dihydro-11-(1-ethoxy-carbonyl-4-piperidylidene)-5H-benzo[5,6]cyclopepta[1,2-b]pyridine[loratadine][P]. ES:2040177,1993-10-01.
  • 9Jackson W P, Antonio G E. New process for the preparation of loratadine[P]. ES:2080700,1996-02-01.
  • 10Inalci L,Manuel M,Julian G,et al.New selective histamine H,receptor and platelet-activating factor (PAF) antagonist[J].Drugs Today,2003,39 (6):451-468.

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部